| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/2010 | US20100016356 Method for treating thrombosis and inhibiting platelet aggregation with 21-(s)-argatroban |
| 01/21/2010 | US20100016355 Alpha-2b adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain |
| 01/21/2010 | US20100016354 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 01/21/2010 | US20100016353 Benzoimidazole derivatives useful as antiproliferative agents |
| 01/21/2010 | US20100016352 Compounds and methods for treating estrogen receptor-related diseases |
| 01/21/2010 | US20100016351 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 01/21/2010 | US20100016350 Novel mch receptor antagonists |
| 01/21/2010 | US20100016349 Pseudoazulenyl nitrones |
| 01/21/2010 | US20100016348 Orally disintegrative dosage form |
| 01/21/2010 | US20100016347 Series of skin whitening (lightening) compounds |
| 01/21/2010 | US20100016345 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 01/21/2010 | US20100016344 Amino heterocyclic linked pyrimidine derivatives |
| 01/21/2010 | US20100016343 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | US20100016342 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 01/21/2010 | US20100016341 Aspartyl protease inhibitors containing a tricyclic ring system |
| 01/21/2010 | US20100016340 Pharmaceutical compounds |
| 01/21/2010 | US20100016338 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents |
| 01/21/2010 | US20100016337 Heteroaryl-substituted carboxamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016336 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/21/2010 | US20100016335 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/21/2010 | US20100016334 Pharmaceutical formulations containing dopamine receptor ligands |
| 01/21/2010 | US20100016333 Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus |
| 01/21/2010 | US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 01/21/2010 | US20100016331 Novel compounds |
| 01/21/2010 | US20100016330 Novel Derivatives |
| 01/21/2010 | US20100016329 Xanthine-based cyclic gmp-enhancing rho-kinase inhibitor inhibits physiological activities of lung epithelial cell line |
| 01/21/2010 | US20100016328 Pterin analogs |
| 01/21/2010 | US20100016327 Quinoline compounds |
| 01/21/2010 | US20100016326 Concentrated methotrexate solutions |
| 01/21/2010 | US20100016325 Tetrahydrocinnoline derivatives |
| 01/21/2010 | US20100016324 Pharmaceutical compositions for the treatment of cellulite |
| 01/21/2010 | US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/21/2010 | US20100016322 Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same |
| 01/21/2010 | US20100016321 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulator |
| 01/21/2010 | US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/21/2010 | US20100016319 Arylmethylene urea derivative and use thereof |
| 01/21/2010 | US20100016318 Anthranilamide inhibitors of aurora kinase |
| 01/21/2010 | US20100016317 Hiv inhibiting 6-substituted pyrimidines |
| 01/21/2010 | US20100016316 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/21/2010 | US20100016315 Iminopyridine Derivative and Use Thereof |
| 01/21/2010 | US20100016314 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 01/21/2010 | US20100016313 Intestinal alkaline phosphatase modulators and uses thereof |
| 01/21/2010 | US20100016312 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | US20100016311 Novel minor groove binders |
| 01/21/2010 | US20100016310 Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors |
| 01/21/2010 | US20100016309 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparation Process therefor and Pharmaceutical Composition Containing the Same |
| 01/21/2010 | US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease |
| 01/21/2010 | US20100016307 Novel compounds |
| 01/21/2010 | US20100016306 Pyrimidine derivatives as pi3k inhibitors |
| 01/21/2010 | US20100016305 novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 01/21/2010 | US20100016304 Glucokinase activator |
| 01/21/2010 | US20100016303 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 01/21/2010 | US20100016302 7-tert-Butyl-3-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-3H-quinazolin-4-one; arthritis; inhibit Btk |
| 01/21/2010 | US20100016301 6-Dimethylamino-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-imidazo[1,2-b]pyridazin-6-yl }-phenyl)-3,4-dihydro-2H-isoquinolin-1-one; asthma, lupus ; inhibit Btk |
| 01/21/2010 | US20100016300 Imidazoacridine Compounds for Treating FLT3-Mediated Disorders |
| 01/21/2010 | US20100016299 Substituted benzoxepino-isoxazoles and use thereof |
| 01/21/2010 | US20100016298 Theramutein modulators |
| 01/21/2010 | US20100016297 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| 01/21/2010 | US20100016296 Heteroaryl compounds and uses thereof |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | US20100016294 Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia |
| 01/21/2010 | US20100016293 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use |
| 01/21/2010 | US20100016292 Inhibitors of lethal factor protease |
| 01/21/2010 | US20100016291 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 01/21/2010 | US20100016290 Amorphous polymorph of bazedoxifene acetate |
| 01/21/2010 | US20100016289 Compounds Useful as Antagonists of CCR2 |
| 01/21/2010 | US20100016288 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 01/21/2010 | US20100016287 Compounds having affinity for dopamine d3 receptor and uses thereof" |
| 01/21/2010 | US20100016286 Anti-Inflammatory Agents |
| 01/21/2010 | US20100016285 Heterocyclidene-n-(aryl) acetamide derivative |
| 01/21/2010 | US20100016284 Compounds and uses thereof - 151 |
| 01/21/2010 | US20100016283 Compounds and uses thereof - 150 |
| 01/21/2010 | US20100016282 Novel heterocyclyl compounds |
| 01/21/2010 | US20100016281 Pyrimidine compounds as serotonin receptor modulators |
| 01/21/2010 | US20100016280 Low Dosage Serotonin 5-HT2A Receptor Agonist To Suppress Inflammation |
| 01/21/2010 | US20100016279 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 |
| 01/21/2010 | US20100016278 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016277 Diazabicyclic central nervous system active agents |
| 01/21/2010 | US20100016276 Compositions and methods for the identification of a carbapenemase gene |
| 01/21/2010 | US20100016275 Novel compound 395 |
| 01/21/2010 | US20100016274 Beta-lactam cannabinoid receptor modulators |
| 01/21/2010 | US20100016273 Use of Ezetimibe in the Prevention and Treatment of Cholesterol Gallstones |
| 01/21/2010 | US20100016272 Heteroarylacrylamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016271 Anti-dandruff hair conditioning compositions |
| 01/21/2010 | US20100016270 Bridged polycyclic compound based compositions for controlling cholesterol levels |
| 01/21/2010 | US20100016269 Composition of plant sterol and phosphatidylcholine and method for producing the same |
| 01/21/2010 | US20100016268 Method and system for dermal tissue treatment |
| 01/21/2010 | US20100016267 Pharmaceutical compositions for administraton to a sinus |
| 01/21/2010 | US20100016266 Pyridine Imidazoles and Aza-indoles as Progesterone Receptor Modulators |
| 01/21/2010 | US20100016265 Anti-inflammatory composition and method for preparation |
| 01/21/2010 | US20100016264 Treatment for dry eye using testosterone and progestagen |
| 01/21/2010 | US20100016263 9, 10-secopregnane derivative and pharmaceutical |
| 01/21/2010 | US20100016262 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis |
| 01/21/2010 | US20100016261 Chemical compounds |
| 01/21/2010 | US20100016260 Agonists of sphingosine-1 phosphate receptor (slp) |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100016258 Phosphonate derivatives as autotaxin inhibitors |
| 01/21/2010 | US20100016257 Method of treatment for osteoarthritis by local intra-articular injection of microparticles |
| 01/21/2010 | US20100016256 Taxane Compounds for Treating Eye Disease |
| 01/21/2010 | US20100016255 Method of treating vitamin b12 deficiency |